HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy. [electronic resource]
- Transplantation proceedings Feb 1993
- 210-1 p. digital
Publication Type: Journal Article
0041-1345
Antilymphocyte Serum--therapeutic use Costs and Cost Analysis Cyclosporine--therapeutic use Graft Rejection HLA-DR Antigens--analysis Histocompatibility Testing Humans Immunosuppression Therapy--methods Kidney Transplantation--economics Prednisolone--therapeutic use Retrospective Studies Survival Analysis Transplantation, Homologous